Results 241 to 250 of about 809,825 (355)

Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas [PDF]

, 2018
Walter Fiedler, Sara Cresta, Henning Schulze‐Bergkamen, Sara De Dosso, Jens Weidmann, Anna Tessari, Hans Baumeister, Antje Danielczyk, Bruno Dietrich, Steffen Goletz, Alfredo Zurlo, Marc Salzberg, Cristiana Sessa, Luca Gianni   +13 more
openalex   +1 more source

Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: Clinical outcomes and response to erlotinib

Cancer, 2015
J. Naidoo, C. Sima, K. Rodriguez, N. Busby, K. Nafa, M. Ladanyi, Gregory Riely, M. Kris, M. Arcila, H. Yu   +9 more
semanticscholar   +1 more source

Beyond Bioactive Glass Composition: Using Morphology to Improve in Vitro and in Vivo Performance

Advanced Healthcare Materials, EarlyView.
Bioactive glasses can easily be shaped into granules, spheres, discs, fibers, or three‐dimensional scaffolds. The resulting morphology not only affects handling properties; it has a direct influence on various glass properties, including results of acellular immersion experiments or in vitro studies with cells or bacteria, but also on in vivo ...
Meixin Su, Mert Ergin, Diana Horkavcová, Victoria Horbert, Georg Matziolis, Delia S. Brauer   +5 more
wiley   +1 more source

Comparative analysis of first-generation epidermal growth factor receptor inhibitors combined with chemotherapy versus third-generation epidermal growth factor receptor inhibitors in the treatment of advanced non-small cell lung cancer: a systematic review and meta-analysis. [PDF]

Front Pharmacol
Peng S, Yu Z, Zhu H, Liang C, Qiu H, Hong S, Zhou Y.   +6 more
europepmc   +1 more source

N-Glycosylation as determinant of epidermal growth factor receptor conformation in membranes

Proceedings of the National Academy of Sciences of the United States of America, 2015
K. Kaszuba, M. Grzybek, A. Orłowski, R. Danne, T. Róg, K. Simons, Ü. Coskun, I. Vattulainen   +7 more
semanticscholar   +1 more source

Construction, expression, and characterization of rSEA-EGF and in vitro evaluation of its antitumor activity against nasopharyngeal cancer [PDF]

, 2018
He, Ying, Liu, Xueting, Tao, Ailin, Wang, Shan, Xie, Yang, Zeng, Liping, Zhang, Jianguo, Zhang, Junyan, Zhou, Zhongqiu, Zou, Zehong   +9 more
core   +2 more sources

Current Challenges in Hemostasis and Advances in Particle‐Assisted Styptic Devices

Advanced Healthcare Materials, EarlyView.
Here persistent limitations in hemostatic technologies are highlighted and cutting‐edge biomimetic, microparticle‐assisted, and nanoengineered systems with integrated drug delivery are showcased. Moreover, the article identifies fresh directions toward the next‐generation of multifunctional hemostatic devices with superior efficacy and accessibility ...
Daniele Baiocco, Zhibing Zhang, Neil M. Eisenstein, Nigel Tai, Liam M. Grover   +4 more
wiley   +1 more source

EGFRp4 Peptides: A Novel Strategy for Epidermal Growth Factor Receptor (EGFR) Inhibitor. [PDF]

ACS Omega
Jiwacharoenchai N, Kiriwan D, Chang SY, Weng CC, Li YK, Tabtimmai L, Choowongkomon K.   +6 more
europepmc   +1 more source

Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer.

Journal of Clinical Oncology, 2014
J. Baselga, J. Cortés, S. Im, E. Clark, G. Ross, A. Kiermaier, S. Swain   +6 more
semanticscholar   +1 more source

A Heparin‐Functionalized Scaffold with HB‐EGF Immobilization for Tissue Engineering

Advanced Healthcare Materials, EarlyView.
In this study, a heparin‐functionalized scaffold is designed for bio‐mimicking growth factors reservoir function of extracellular matrix. Due to the presence of heparin‐binding domain, heparin‐binding epidermal growth factor‐like growth factor (HB‐EGF) is effectively and spatially captured by heparin‐functionalized scaffold.
Bowu Peng, Huajian Chen, Chengyu Lu, Tianjiao Zeng, Man Wang, Toru Yoshitomi, Naoki Kawazoe, Yingnan Yang, Guoping Chen   +8 more
wiley   +1 more source